Aruna Gullapalli, MD
Psychiatry · Monroe, LANPI 1154303261
Payments from drug & device makers
Across 532 payments — averaging $540.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$202K
- E.r. Squibb & Sons, L.L.C.$76K
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$1K
- Sunovion Pharmaceuticals Inc.$856
- Alkermes, Inc.$781
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 54 | $201,687 |
| E.r. Squibb & Sons, L.L.C. | 6 | $75,742 |
| AbbVie(2 entities) | 152 | $2,964 |
| Otsuka America Pharmaceutical, Inc. | 17 | $1,233 |
| Sunovion Pharmaceuticals Inc. | 48 | $856 |
| Alkermes, Inc. | 46 | $781 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $562 |
| Teva Pharmaceuticals USA, Inc. | 23 | $441 |
| Corium, LLC | 19 | $412 |
| Neurocrine Biosciences, Inc. | 16 | $396 |
| Johnson & Johnson | 23 | $361 |
| Lundbeck LLC | 21 | $339 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $274 |
| Axsome Therapeutics, Inc. | 7 | $181 |
| Shire North American Group Inc | 8 | $172 |
| Vanda Pharmaceuticals Inc. | 9 | $171 |
| Supernus Pharmaceuticals, Inc. | 8 | $164 |
| Indivior Inc. | 8 | $159 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Eisai Inc. | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 4 | $62 |
| Noven Therapeutics, LLC | 3 | $59 |
| Adlon Therapeutics L.p. | 2 | $37 |
| Merck | 2 | $36 |
| Neos Therapeutics, LP | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Neuronetics, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
How this compares
$287,332 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Monroe
- Alfredo TorresMonroe$164K
- Kashinath YadalamLake Charles$3.8M
- Guy BrannonShreveport$1.4M
- Patrick HayesLake Charles$853K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Roger BrownMandeville$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.